PMID- 11306626 OWN - NLM STAT- MEDLINE DCOM- 20010607 LR - 20191023 IS - 1529-2401 (Electronic) IS - 0270-6474 (Print) IS - 0270-6474 (Linking) VI - 21 IP - 8 DP - 2001 Apr 15 TI - Spatiotemporal dynamics of brain-derived neurotrophic factor mRNA induction in the vestibulo-olivary network during vestibular compensation. PG - 2738-48 AB - Vestibular compensation, which is the behavioral recovery from vestibular dysfunction produced by unilateral labyrinthectomy (UL), is attributed to functional and structural reorganization of neural networks in the central vestibular system. To assess the possible contribution of brain-derived neurotrophic factor (BDNF) to this recovery process, we investigated changes in mRNA expression levels in the central vestibular system after UL. We evaluated BDNF mRNA expression levels by quantitative reverse transcription-PCR and in situ hybridization. We found that BDNF mRNA is differentially induced in the medial vestibular nucleus ipsilateral to UL and in the prepositus hypoglossi and inferior olive on the contralateral side. The BDNF mRNA induction lasted for at least 24 hr and returned to the basal expression level within 72 hr after UL. In contrast to BDNF mRNA induction, the expression of an immediate-early gene, c-fos, quickly reached the maximum level at 3 hr and decreased to the basal level within 24 hr after UL. Neither BDNF or c-fos induction was observed in sham-operated animals. The persistent induction of BDNF after UL temporally corresponded to early behavioral manifestations of vestibular compensation. We further found that trkB mRNA was expressed in the central vestibular network at high levels, although its expression levels did not change over time after UL. Because BDNF is implicated in regulating synaptic structure and function, these results provide support for the hypothesis that BDNF is involved in neuronal reorganization that allows vestibular compensation. FAU - Li, Y X AU - Li YX AD - Mind Articulation Project, International Cooperative Research Project, Japan Science and Technology Corporation, Yushima, Tokyo 113-0034, Japan. FAU - Hashimoto, T AU - Hashimoto T FAU - Tokuyama, W AU - Tokuyama W FAU - Miyashita, Y AU - Miyashita Y FAU - Okuno, H AU - Okuno H LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Neurosci JT - The Journal of neuroscience : the official journal of the Society for Neuroscience JID - 8102140 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Proto-Oncogene Proteins c-fos) RN - 0 (RNA, Messenger) RN - EC 2.7.10.1 (Receptor, trkB) SB - IM MH - Adaptation, Physiological MH - Animals MH - Brain-Derived Neurotrophic Factor/genetics/*metabolism MH - Gene Expression Regulation MH - In Situ Hybridization MH - Male MH - Nerve Net/cytology/*metabolism MH - Neuronal Plasticity/physiology MH - Olivary Nucleus/cytology/*metabolism MH - Otologic Surgical Procedures MH - Proto-Oncogene Proteins c-fos/biosynthesis/genetics MH - RNA, Messenger/*metabolism MH - Rats MH - Rats, Wistar MH - Receptor, trkB/genetics/metabolism MH - Reverse Transcriptase Polymerase Chain Reaction MH - Vestibule, Labyrinth/cytology/innervation/*metabolism PMC - PMC6762513 EDAT- 2001/04/18 10:00 MHDA- 2001/06/08 10:01 PMCR- 2001/10/15 CRDT- 2001/04/18 10:00 PHST- 2001/04/18 10:00 [pubmed] PHST- 2001/06/08 10:01 [medline] PHST- 2001/04/18 10:00 [entrez] PHST- 2001/10/15 00:00 [pmc-release] AID - 21/8/2738 [pii] AID - 5134 [pii] AID - 10.1523/JNEUROSCI.21-08-02738.2001 [doi] PST - ppublish SO - J Neurosci. 2001 Apr 15;21(8):2738-48. doi: 10.1523/JNEUROSCI.21-08-02738.2001.